Revvity Schedules Q3 2026 Earnings Call Amid Revenue Growth

  • Revvity will release Q3 2026 financial results on November 3, 2026, ahead of market open.
  • CEO Prahlad Singh and CFO Max Krakowiak will host the earnings call at 7:30 a.m. ET.
  • Revvity reported $2.9 billion in revenue for 2025 with 11,000 employees globally.
  • The company serves customers in over 160 countries across pharmaceuticals, biotech, and diagnostics.

Revvity's upcoming earnings call comes at a critical juncture as the company seeks to maintain its growth trajectory in the competitive healthcare technology sector. With a focus on translational multi-omics and diagnostic solutions, Revvity's performance will be closely watched by investors and industry analysts. The company's ability to innovate and scale its operations will be key factors in its continued success.

Revenue Growth
How Revvity's Q3 2026 results will reflect its ability to sustain momentum after a strong 2025.
Market Expansion
Whether Revvity can continue expanding its customer base in over 160 countries.
Operational Efficiency
The pace at which Revvity integrates its diverse health science solutions into seamless workflows.